A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011-Reference-Cited by-同舟云学术

A pilot validation in 10 European Union Member States of a point prevalence survey of healthcare-associated infections and antimicrobial use in acute hospitals in Europe, 2011

Published:2015-02-26 Issue:8 Volume:20 Page:
ISSN:1560-7917
Container-title:Eurosurveillance
language:en
Short-container-title:

Author:

Reilly J S¹,Price L¹,Godwin J¹,Cairns S²,Hopkins S³,Cookson B³⁴,Malcolm W²,Hughes G³,Lyytikaïnen O⁵,Coignard B⁶,Hansen S⁷,Suetens C⁸,National Participants in the ECDC pilot validation study Collective⁹

Affiliation:

1. Glasgow Caledonian University, Glasgow, United Kingdom

2. Health Protection Scotland, Glasgow, United Kingdom

3. Public Health England, London, United Kingdom

4. University College London, United Kingdom (current affiliation)

5. National Institute for Health and Welfare, Helsinki, Finland

6. Institut de Veille Sanitaire, Saint-Maurice, France

7. Charité University Medicine Berlin, Germany

8. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

9. The participants are listed at the end of the article

Abstract

Binary file ES_Abstracts_Final_ECDC.txt matches

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference19 articles.

1. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals, 2011–2012. Stockholm: ECDC; 2013. Available from: http://www.ecdc.europa.eu/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf

2. Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17(46):pii=2031. PMID:23171822

3. European Centre for Disease Prevention and Control (ECDC). Pilot validation study of the ECDC Point Prevalence Survey of healthcare-associated Infections and Antimicrobial Use in European Acute Care Hospitals. OG/23/06/2011-PROC/2011/060. Stockholm: ECDC; 2011. Available from: http://www.ecdc.europa.eu/en/aboutus/calls/_layouts/forms/Call_DispForm.aspx?List=02511b7b-3a16-4c4b-9304-54cfc08a1647&ID=586

4. European Centre for Disease Prevention and Control (ECDC). PPS Validation Protocol version 2.1 Stockholm: ECDC; 2014. Available from: http://www.ecdc.europa.eu/en/publications/Publications/HAI-PPS-Validation-protocol-Sept-2014.pdf

5. European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated Infections and antimicrobial use in European acute care hospitals: protocol version 4.3. Stockholm: ECDC, 2012 Available from: http://www.ecdc.europa.eu/en/publications/publications/0512-ted-pps-hai-antimicrobial-use-protocol.pdf

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. China Against Drug Resistance (CARE) Point Prevalence Study: A Tool for Evaluating Hospital Acquired Infections and Antimicrobial Prescription at Patient Bedside;Open Medicine Journal;2024-08-08

2. Pilot validation of central line-associated bloodstream infection data in a voluntary surveillance system in Taiwan between October and December 2021;Infection Prevention in Practice;2024-03

3. Appropriate antimicrobial agent usage: the beginning of a journey;Brazilian Journal of Pharmaceutical Sciences;2024

4. The WHO methodology for point prevalence surveys on antibiotics use in hospitals should be improved: Lessons from pilot studies in four Mexican hospitals;International Journal of Infectious Diseases;2021-07

5. Development of case vignettes for assessment of the inter-rater variability of national validation teams for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals;Journal of Hospital Infection;2019-04